Antimicrobial Agents and Chemotherapy 1982-05-01

In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.

M Arisawa, J Ohshima, E Ohsawa, H B Maruyama

Index: Antimicrob. Agents Chemother. 21(5) , 706-10, (1982)

Full Text: HTML

Abstract

Potentiating activity of alafosfalin was examined in detail with 8 cephalosporins and mecillinam against 164 urinary bacteria representing 8 genera. Alafosfalin was generally comparable in activity to cefamandole and mecillinam but superior to other cephalosporins tested. When the minimal fractional inhibitory concentration indices were compared, synergism was observed with all of the beta-lactams tested for all species except Streptococcus faecalis. Marked synergism was observed with Escherichia coli, Citrobacter, and enterobacter and, among the drugs tested, with cefamandole and mecillinam. Although alafosfalin is inactive against Pseudomonas aeruginosa, potentiation was seen with cefsulodin. The most favorable combination ratio of alafosfalin/cephalosporin to elicit potentiation was determined for each species and occurred in a rather narrow range of combinations (1:4 to 4:1 in general).


Related Compounds

Related Articles:

Alafosfalin as a selective agent for isolation of salmonella from clinical samples.

2002-11-01

[J. Clin. Microbiol. 40(11) , 3913-6, (2002)]

Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.

1984-05-01

[Antimicrob. Agents Chemother. 25(5) , 607-11, (1984)]

In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.

1980-01-01

[Chemotherapy 26(2) , 103-10, (1980)]

Alafosfalin, a new synthetic antibacterial compound.

1981-02-01

[Naturwissenschaften 68(2) , 90, (1981)]

Recent developments in the field of phosphonic acid antibiotics.

1984-10-01

[J. Antimicrob. Chemother. 14(4) , 309-11, (1984)]

More Articles...